HOME Top Market Reports In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020

In Vitro Diagnostics (IVD) Market by Product (instruments, Reagents, Software, Service) Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020

By: marketsandmarkets.com
Publishing Date: July 2015
Report Code: MD 3609

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global In Vitro Diagnostics Market is expected to reach $75.1 Billion by 2020, at a CAGR of 5.8% from 2015 to 2020. The global IVD market has evolved over the years with launch of number of innovative techniques having applications across multiple therapeutic areas. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases across the globe, growing aging population, and increasing usage of point-of-care testing and personalized medicine. Moreover, a new range of condition-specific markers and tests with advances in genomics and proteomics and increasing investment in emerging countries are creating new opportunities for this market. However, inadequate reimbursement and stringent regulatory approval framework are restraining the growth of this market.

Geographically, North America is the largest regional segment of this market, with a share of ~43% in 2014. The large share of this region can be attributed to the presence of advanced technologies, superlative opportunities for molecular diagnostics in genetic testing and cancer screening, established distribution channels in the region, and the presence of a large number of leading market players such as Abbott Laboratories, Inc., Johnson and Johnson, Becton, Dickson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., and Alere, Inc. (U.S.).

The global In Vitro Diagnostics market is highly competitive, and is dominated by five players that together account for ~57% of the global market in 2014. However, new local players in the market are intensifying competition and thereby threatening the market shares of existing players. In order to maintain their shares, leading players are continuously adopting various strategies. This increased competitiveness is expected to drive innovation in the market and thereby help the industry to solve existing challenges and meet the needs of end users.

Roche Diagnostics (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Ortho-Clinical Diagnostics (U.S.), Johnson and Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), and bioMιrieux (France) are the major players in the global In Vitro Diagnostics market.

Scope of the Report

This research report categorizes the global In Vitro Diagnostics market on the basis of products, technologies, applications, end users, and regions. Each market is comprehensively analyzed by region (North America, Europe, Asia-Pacific, and the Rest of the World) to provide in-depth information on the global scenario.

Global In Vitro Diagnostics Market

This research report categorizes the global in vitro diagnostics market into the following segments:

In Vitro Diagnostics Market, by Product

  • Instruments
  • Reagents and Kits
  • Data Management System/Software
  • Services

In Vitro Diagnostics Market, by Technology

  • Clinical Chemistry
    • Basic Metabolic Panel
    • Electrolyte Panel
    • Liver Panel
    • Lipid Profile
    • Renal Profile
    • Thyroid Function Panel
    • Specialty Chemicals
  • Immunochemistry/Immunoassays
    • Enzyme-linked Immunosorbent Assay (ELISA)
      • Chemiluminescence Immunoassay (CLIA)
      • Fluorescence Immunoassay (FIA)
      • Colorimetric Immunoassay (CI)
    • Radioimmunoassays (RIA)
    • Rapid Tests
    • Western Blot
    • ELISPOT
  • Hematology
  • Coagulation and Hemostasis
  • Microbiology
  • Molecular Diagnostics
    • Polymerase Chain Reaction (PCR)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Hybridization (In Situ Hybridization and FISH)
    • DNA Sequencing and NGS
    • Microarray
    • Others
  • Other IVD Technologies

In Vitro Diagnostics Market, by Application

  • Diabetes
  • Infectious Diseases
  • Oncology/Cancer
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • HIV/AIDS
  • Other Applications

In Vitro Diagnostics Market, by End User

  • Laboratories
  • Hospitals
  • Academic Institutes
  • Point-of-care Testing
  • Patient Self-testing
  • Other End Users

In Vitro Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Russia
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America (ROLA)
    • Middle East and Africa

Table of Contents

1 Introduction (Page No. - 14)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
                    2.1.2.3 Breakdown of Primary Interviews
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 25)

4 Premium Insights (Page No. - 31)
    4.1 Growth Potential of the IVD Market
    4.2 North America: IVD Market
    4.3 IVD Market: Geographic Snapshot
    4.4 Geographic Mix: IVD Market, By Technology
    4.5 IVD Market: Emerging vs Developed Markets

5 Market Overview (Page No. - 36)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 In Vitro Diagnostics Market, By Product
           5.2.2 In Vitro Diagnostics Market, By Technology
           5.2.3 In Vitro Diagnostics Market, By Application
           5.2.4 In Vitro Diagnostics Market, By End User
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Rising Incidence of Chronic Lifestyle Diseases Across the Globe
                    5.3.1.2 Rapid Growth in the Geriatric Population
                    5.3.1.3 Increasing Adoption of Point-Of-Care (POC) Testing
                    5.3.1.4 Growing Awareness of Personalized Medicine
           5.3.2 Restraints
                    5.3.2.1 Inadequate Reimbursement
                    5.3.2.2 Implementation of Excise Duty By the U.S. Government
           5.3.3 Opportunities
                    5.3.3.1 New Range of Condition-Specific Markers and Tests With Advances in Genomics and Proteomics
                    5.3.3.2 Emerging Economies With Increasing Investments
           5.3.4 Challenges
                    5.3.4.1 Stringent Regulatory Framework

6 Industry Insights (Page No. - 48)
    6.1 Introduction
    6.2 Industry Trends
    6.3 Porter’s Five Force Analysis
           6.3.1 Threat From New Entrants
           6.3.2 Threat of Substitutes
           6.3.3 Bargaining Power of Suppliers
           6.3.4 Bargaining Power of Buyers
           6.3.5 Intensity of Competitive Rivalry
    6.4 Regulatory Analysis
           6.4.1 North America
                    6.4.1.1 U.S.
                    6.4.1.2 Canada
           6.4.2 Europe
           6.4.3 Asia-Pacific
                    6.4.3.1 Japan
                    6.4.3.2 China
                    6.4.3.3 India
                    6.4.3.4 Australia

7 Global IVD Market, By Product & Service (Page No. - 57)
    7.1 Introduction
    7.2 Reagents & Kits
    7.3 Instruments
    7.4 Data Management Software/Hardware
    7.5 Services

8 Global IVD Market, By Technology (Page No. - 69)
    8.1 Introduction
    8.2 Clinical Chemistry
           8.2.1 Basic Metabolic Panel
           8.2.2 Electrolyte Panels
           8.2.3 Liver Panels
           8.2.4 Lipid Profiles
           8.2.5 Renal Profiles
           8.2.6 Thyroid Function Panels
           8.2.7 Specialty Chemical Tests
    8.3 Immunochemistry/Immunoassays
           8.3.1 Elisa
                    8.3.1.1 Chemiluminescence Immunoassays (CLIAs)
                    8.3.1.2 Fluorescence Immunoassays (FIA)
                    8.3.1.3 Colorimetric Immunoassays (CI)
           8.3.2 Radioimmunoassays (RIA)
           8.3.3 Rapid Tests
           8.3.4 Western Blot
           8.3.5 Elispot
    8.4 Hematology
    8.5 Coagulation and Hemostasis
    8.6 Microbiology
    8.7 Molecular Diagnostics (MDX)
           8.7.1 Polymerase Chain Reaction (PCR)
           8.7.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
           8.7.3 Microarrays
           8.7.4 Hybridization
           8.7.5 Dna Sequencing & Next-Generation Sequencing
           8.7.6 Others
    8.8 Others

9 In Vitro Diagnostics Market, By Application (Page No. - 121)
    9.1 Introduction
    9.2 Diabetes
    9.3 Infectious Diseases
    9.4 Oncology/Cancer
    9.5 Cardiology
    9.6 Nephrology
    9.7 Autoimmune Diseases
    9.8 Drug Testing
    9.9 HIV/AIDS
    9.1 Other Applications

10 Global IVD Market, By End User (Page No. - 141)
     10.1 Introduction
     10.2 Laboratories
     10.3 Hospitals
     10.4 Academic Institutes
     10.5 Point-Of-Care Testing
     10.6 Patient Self-Testing
     10.7 Others

11 Geographic Analysis Key Findings (Page No. - 153)
     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 U.K.
             11.3.4 Italy
             11.3.5 Spain
             11.3.6 Russia
             11.3.7 Rest of Europe (RoE)
     11.4 Asia-Pacific (APAC)
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia-Pacific (RoAPAC)
     11.5 Rest of the World (RoW)
             11.5.1 Latin America
                        11.5.1.1 Brazil
                        11.5.1.2 Mexico
                        11.5.1.3 Rest of Latin America (RoLA)
             11.5.2 Middle East and Africa

12 Competitive Landscape (Page No. - 230)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Situation and Trends
     12.4 New Product Launches
     12.5 Agreements, Partnerships, and Collaborations
     12.6 Mergers and Acquisitions
     12.7 Expansions

13 Company Profiles  (Page No. - 237)
     13.1 Abbott Laboratories, Inc.
             13.1.1 Business Overview
             13.1.2 Products Offered
             13.1.3 Services Offered
             13.1.4 Recent Developments
             13.1.5 MnM View
     13.2 Roche Diagnostics
             13.2.1 Business Overview
             13.2.2 Products Offered
             13.2.3 Recent Developments
             13.2.4 MnM View
     13.3 Biomιrieux
             13.3.1 Business Overview
             13.3.2 Products Offered
             13.3.3 Recent Developments
     13.4 Ortho Clinical Diagnostics, Inc.
             13.4.1 Business Overview
             13.4.2 Products Offered
             13.4.3 Recent Developments
     13.5 Bio-Rad Laboratories, Inc.
             13.5.1 Business Overview
             13.5.2 Products Offered
             13.5.3 Services Offered
             13.5.4 Recent Developments
     13.6 Danaher Corporation
             13.6.1 Business Overview
             13.6.2 Products Offered
             13.6.3 Services Offered
             13.6.4 Recent Developments
             13.6.5 MnM View
     13.7 Johnson and Johnson
             13.7.1 Business Overview
             13.7.2 Products Offered
             13.7.3 Recent Developments
             13.7.4 MnM View
     13.8 Siemens Healthcare
             13.8.1 Business Overview
             13.8.2 Products Offered
             13.8.3 Services Offered
             13.8.4 Recent Developments
             13.8.5 MnM View
     13.9 Sysmex Corporation
             13.9.1 Business Overview
             13.9.2 Products Offered
             13.9.3 Services Offered
             13.9.4 Recent Developments
     13.10 Becton, Dickinson and Company
             13.10.1 Business Overview
             13.10.2 Products Offered
             13.10.3 Recent Developments
     13.11 Thermo Fisher Scientific, Inc.
             13.11.1 Business Overview
             13.11.2 Products Offered
             13.11.3 Services Offered
             13.11.4 Recent Developments

14 Appendix (Page No. - 296)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 O Ther Developments, 2012–2015
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports


List of Tables (162 Tables)

Table 1 Increased Incidence of Chronic Lifestyle Diseases and Rapid Growth in Geriatric Population Will Drive the Market Growth
Table 2 Lack of Budget and Implementation of Excise Duty to Restrain the Market Growth
Table 3 Emerging Economies With Increasing Investments Offer Significant Opportunities for Market Growth
Table 4 Stringent Regulatory Framework is A Major Challenge
Table 5 Global In Vitro Diagnostics Market, By Product & Service, 2013–2020 (USD Million)
Table 6 Global In Vitro Diagnostics Reagents & Kits Market Size, By Country, 2013–2020 (USD Million)
Table 7 Global In Vitro Diagnostics Reagents & Kits Market Size, By Technology, 2013–2020 (USD Million)
Table 8 Global In Vitro Diagnostics Instruments Market Size, By Country, 2013–2020 (USD Million)
Table 9 Global IVD Instruments Market Size, By Technology, 2013–2020 (USD Million)
Table 10 Global Data Management System Software/Hardware Market Size, By Country, 2013–2020 (USD Million)
Table 11 Global IVD Data Management System Software/Hardware Market Size, By Technology, 2013–2020 (USD Million)
Table 12 Global In Vitro Diagnostics Services Market Size, By Country, 2013–2020 (USD Million)
Table 13 Global IVD Services Market Size, By Technology, 2013–2020 (USD Million)
Table 14 Global In Vitro Diagnostics Market, By Technology, 2013 – 2020 (USD Million)
Table 15 Global Clinical Chemistry Market Size, By Country, 2013–2020 (USD Million)
Table 16 Global Clinical Chemistry Market Size, By Test, 2013–2020 (USD Million)
Table 17 Global Basic Metabolic Panels Market Size, By Country, 2013–2020 (USD Million)
Table 18 Global Electrolyte Panels Market Size, By Country, 2013–2020 (USD Million)
Table 19 Global Liver Panels Market Size, By Country, 2013–2020 (USD Million)
Table 20 Global Lipid Profiles Market Size, By Country, 2013–2020 (USD Million)
Table 21 Global Renal Profiles Market Size, By Country, 2013–2020 (USD Million)
Table 22 Global Thyroid Function Panels Market Size, By Country, 2013–2020 (USD Million)
Table 23 Global Specialty Chemical Tests Market Size, By Country, 2013–2020 (USD Million)
Table 24 Global Immunoassay/Immunochemistry Market Size, By Type, 2013–2020 (USD Million)
Table 25 Global Immunoassay/Immunochemistry Market Size, By Country, 2013–2020 (USD Million)
Table 26 Global Elisa Market Size, By Country, 2013–2020 (USD Million)
Table 27 Global Chemiluminescence Immunoassays (CLIA) Market Size, By Country, 2013–2020 (USD Million)
Table 28 Global Fluorescence Immunoassays Market Size, By Country, 2013–2020 (USD Million)
Table 29 Global Colorimetric Immunoassays Market Size, By Country, 2013–2020 (USD Million)
Table 30 Global Radioimmunoassays Market Size, By Country, 2013–2020 (USD Million)
Table 31 Global Rapid Tests Market Size, By Country, 2013–2020 (USD Million)
Table 32 Global Western Blot Market Size, By Country, 2013–2020 (USD Million)
Table 33 Global Elispot Market Size, By Country, 2013–2020 (USD Million)
Table 34 Global Hematology Market Size, By Country, 2013–2020 (USD Million)
Table 35 Global Coagulation & Hemostasis Market Size, By Country, 2013–2020 (USD Million)
Table 36 Global Microbiology Market Size, By Country, 2013–2020 (USD Million)
Table 37 Global Molecular Diagnostics Market Size, By Country, 2013–2020 (USD Million)
Table 38 Global Molecular Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 39 Global PCR Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 40 Global INAAT Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 41 Global Microarrays Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 42 Global Hybridization Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 43 Global Dna Sequencing & Ngs Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 44 Global Other Technologies Market Size for Molecular Diagnostics, By Country, 2013–2020 (USD Million)
Table 45 Global Other Technologies Market Size, By Country, 2013–2020 (USD Million)
Table 46 Global In Vitro Diagnostics Market Size, By Application, 2013 – 2020 (USD Million)
Table 47 Global Diabetic Patient Population (2014)
Table 48 Global  Market Size for Diabetes, By Country, 2013–2020 (USD Million)
Table 49 Global In Vitro Diagnostics Market Size for Infectious Diseases, By Country, 2013–2020 (USD Million)
Table 50 Global In Vitro Diagnostics Market Size for Oncology, By Country, 2013–2020 (USD Million)
Table 51 Global Market Size for Cardiology, By Country, 2013–2020 (USD Million)
Table 52 Global Market Size for Nephrology, By Country, 2013–2020 (USD Million)
Table 53 Global In Vitro Diagnostics Market Size for Autoimmune Diseases, By Country, 2013–2020 (USD Million)
Table 54 Global Market Size for Drug Testing, By Country, 2013–2020 (USD Million)
Table 55 Global In Vitro Diagnostics Market Size for HIV/AIDS, By Country, 2013–2020 (USD Million)
Table 56 Global Market Size for Other Applications, By Country, 2013–2020 (USD Million)
Table 57 Global Market, By End User, 2013–2020 (USD Million)
Table 58 Global IVD Market Size for Laboratories, By Country, 2013–2020 (USD Million)
Table 59 Global In Vitro Diagnostics Market Size for Hospitals, By Country, 2013–2020 (USD Million)
Table 60 Global In Vitro Diagnostics Market Size for Academic Institutes, By Country, 2013–2020 (USD Million)
Table 61 Global Market Size for POC Testing, By Country, 2013–2020 (USD Million)
Table 62 Global In Vitro Diagnostics Market Size for Patient Self-Testing, By Country, 2013–2020 (USD Million)
Table 63 Global Market Size for Other End Users, By Country, 2013–2020 (USD Million)
Table 64 Global Market Size, By Region, 2013–2020 (USD Million)
Table 65 Global In Vitro Diagnostics Market Size, By Country, 2013–2020 (USD Million)
Table 66 North America: In Vitro Diagnostics Market Size, By Country, 2013–2020 (USD Million)
Table 67 North America: IVD Market Size, By Product Type, 2013–2020 (USD Million)
Table 68 North America: In Vitro Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 69 North America: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 70 North America: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 71 U.S.: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 72 U.S.: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 73 U.S.: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 74 U.S.: In Vitro Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 75 Canada: IVD Market Size, By Product Type, 2013–2020 (USD Million)
Table 76 Canada: In Vitro Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 77 Canada: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 78 Canada: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 79 Europe: In Vitro Diagnostics Market Size, By Country, 2013–2020 (USD Million)
Table 80 Europe: IVD Market Size, By Product Type, 2013–2020 (USD Million)
Table 81 Europe: In Vitro Diagnostics Market Size, By Application, 2013–2020 (USD Million)
Table 82 Europe: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 83 Europe: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 84 Germany: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 85 Germany: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 86 Germany: In Vitro Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 87 Germany: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 88 France: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 89 France: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 90 France: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 91 France: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 92 U.K.: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 93 U.K.: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 94 U.K.: In Vitro Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 95 U.K.: In Vitro Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 96 Italy: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 97 Italy: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 98 Italy: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 99 Italy: In Vitro Diagnostics Market Size, By End User, 2013–2020 (USD Million)
Table 100 Spain: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 101 Spain: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 102 Spain: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 103 Spain: Market Size, By End User, 2013–2020 (USD Million)
Table 104 Russia: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 105 Russia: Market Size, By Application, 2013–2020 (USD Million)
Table 106 Russia: In Vitro Diagnostics Market Size, By Technology, 2013–2020 (USD Million)
Table 107 Russia: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 108 RoE: In Vitro Diagnostics Market Size, By Product Type, 2013–2020 (USD Million)
Table 109 RoE: IVD Market Size, By Application, 2013–2020 (USD Million)
Table 110 RoE: IVD Market Size, By Technology, 2013–2020 (USD Million)
Table 111 RoE: IVD Market Size, By End User, 2013–2020 (USD Million)
Table 112 APAC: In Vitro Diagnostics Market Size, By Country, 2013-2020 (USD Million)
Table 113 APAC: Market Size, By Product Type, 2013-2020 (USD Million)
Table 114 APAC: Market Size, By Application, 2013-2020 (USD Million)
Table 115 APAC: In Vitro Diagnostics Market Size, By Technology, 2013-2020 (USD Million)
Table 116 APAC: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 117 Japan: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 118 Japan: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 119 Japan:  Market Size, By Technology, 2013-2020 (USD Million)
Table 120 Japan: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 121 China: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 122 China: Market Size, By Application, 2013-2020 (USD Million)
Table 123 China: In Vitro Diagnostics Market Size, By Technology, 2013-2020 (USD Million)
Table 124 China: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 125 India: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 126 India:  Market Size, By Application, 2013-2020 (USD Million)
Table 127 India: Market Size, By Technology, 2013-2020 (USD Million)
Table 128 India: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 129 RoAPAC: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 130 RoAPAC: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 131 RoAPAC: IVD Market Size, By Technology, 2013-2020 (USD Million)
Table 132 RoAPAC: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 133 RoW: In Vitro Diagnostics Market Size, By Region, 2013-2020 (USD Million)
Table 134 RoW: Market Size, By Product Type, 2013-2020 (USD Million)
Table 135 RoW: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 136 RoW:  Market Size, By Technology, 2013-2020 (USD Million)
Table 137 RoW: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 138 Latin America: In Vitro Diagnostics Market Size, By Country, 2013-2020 (USD Million)
Table 139 Latin America: IVD Market Size, By Product Type, 2013-2020 (USD Million)
Table 140 Latin America: In Vitro Diagnostics Market Size, By Application, 2013-2020 (USD Million)
Table 141 Latin America: Market Size, By Technology, 2013-2020 (USD Million)
Table 142 Latin America: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 143 Brazil: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 144 Brazil: Market Size, By Application, 2013-2020 (USD Million)
Table 145 Brazil:  Market Size, By Technology, 2013-2020 (USD Million)
Table 146 Brazil: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 147 Mexico: In Vitro DiagnosticsMarket Size, By Product Type, 2013-2020 (USD Million)
Table 148 Mexico: Market Size, By Application, 2013-2020 (USD Million)
Table 149 Mexico: Market Size, By Technology, 2013-2020 (USD Million)
Table 150 Mexico: In Vitro Diagnostics Market Size, By End User, 2013-2020 (USD Million)
Table 151 RoLA: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 152 RoLA: Market Size, By Application, 2013-2020 (USD Million)
Table 153 RoLA: Market Size, By Technology, 2013-2020 (USD Million)
Table 154 RoLA: IVD Market Size, By End User, 2013-2020 (USD Million)
Table 155 Middle East and Africa: In Vitro Diagnostics Market Size, By Product Type, 2013-2020 (USD Million)
Table 156 Middle East and Africa: IVD Market Size, By Application, 2013-2020 (USD Million)
Table 157 Middle East and Africa: In Vitro Diagnostics Market Size, By Technology, 2013-2020 (USD Million)
Table 158 Middle East and Africa: In Vitro Diagnostics Market Size, By End User, 2013-2020 (USD Million)
Table 159 New Product Launches, 2012–2015
Table 160 Agreements, Partnerships, and Collaborations, 2012–2015
Table 161 Mergers and Acquisitions, 2012–2015
Table 162 Expansions, 2012–2015


List of Figures (44 Figures)

Figure 1 Global in Vitro Diagnostics Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global In Vitro Diagnostics Market Size, By Products & Services, 2015 vs 2020 (USD Million)
Figure 8 Global IVD Market Size, By Application, 2015 vs 2020 (USD Million)
Figure 9 Global IVD Market Size, By End User, 2015 vs 2020 (USD Million)
Figure 10 IVD Market: Geographic Snapshot
Figure 11 High Growth Potential of Asia-Pacific Provides Significant Opportunities for the Market
Figure 12 Increasing Incidence of Chronic Lifestyle Diseases is Driving Growth in the IVD Market
Figure 13 Reagents & Kits to Account for the Largest Share of the IVD Market in North America
Figure 14 U.S. to Command More Than One-Third of the Global IVD Market
Figure 15 North America to Dominate the Molecular Diagnostics & Microbiology Markets
Figure 16 Emerging Markets are Estimated to Grow at A Higher Rate During the Forecast Period
Figure 17 In Vitro Diagnostics Market Segmentation, By Product
Figure 18 In Vitro Diagnostics Market Segmentation, By Technology
Figure 19 In Vitro Diagnostics Market Segmentation, By Application
Figure 20 In Vitro Diagnostics Market Segmentation, By End User
Figure 21 IVD Market: Drivers, Restraints, Opportunities, & Challenges
Figure 22 Major Trend: Acquisitions Resulting in Market Consolidation
Figure 23 Regulatory Approval Process in China
Figure 24 Regulatory Approval Process in India
Figure 25 Reagents, the Fastest Growing Segment of the IVD Market
Figure 26 Molecular Diagnostics Will Grow at the Highest Cagr During the Forecast Period of 2015-2020
Figure 27 Oncology is the Fastest-Growing Segment of the IVD Market
Figure 28 North America to Dominate the IVD Market
Figure 29 North American IVD Market Overview
Figure 30 European IVD Market Overview
Figure 31 Players Majorly Adopted the Strategy of New Product Launches From 2012 to 2015
Figure 32 Global In Vitro Diagnostics Market Share Analysis, By Key Player, 2014
Figure 33 Battle for Market Share: New Product Launches Was the Key Strategy
Figure 34 Geographic Revenue Mix of the Top 5 Market Players
Figure 35 Company Snapshot: Abbott Laboratories, Inc.
Figure 36 Company Snapshot: F. Hoffmann-La Roche Ltd.
Figure 37 Company Snapshot: Biomιrieux
Figure 38 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 39 Company Snapshot: Danaher Corporation
Figure 40 Company Snapshot: Johnson and Johnson
Figure 41 Company Snapshot: Siemens AG
Figure 42 Company Snapshot: Sysmex Corporation
Figure 43 Company Snapshot: Becton, Dickinson and Company
Figure 44 Company Snapshot: Thermo Fisher Scientific, Inc.

The global in vitro diagnostics market is estimated to reach $75.1 billion by 2020, growing at a CAGR of 5.8% during the forecast period (2015 to 2020). This market is mainly driven by the rising incidences of chronic lifestyle diseases and infectious diseases in emerging economies, rapidly aging population, and increasing adoption of point-of-care testing practices, and growing awareness of personalized medicine. In addition, extending reach of molecular diagnostics and new range of condition-specific markers and tests with advances in genomics and proteomics are creating new opportunities for this market. However, stringent regulatory framework and inadequate reimbursement are restraining the growth of this market.

In this report, the market is segmented on the basis of product, technology, application, end user, and region. The research report discusses the key market drivers, restraints, opportunities, and challenges in this global market and its submarkets.

On the basis of products, the market is segmented into reagents, instruments, services, and data management system/software. In 2014, the reagents segment accounted for the largest share of ~80% of the In Vitro Diagnostics market; this segment is poised to grow at a CAGR of 6.4% during the forecast period. The growth in this market is attributed to the growing demand for reagents in line with an increasing number of diagnostic tests being performed globally every year, and increasing uptake of new reagents that are highly sensitive and provide faster and accurate results.

On the basis of applications, this market is segmented into diabetes, infectious diseases, oncology, cardiology, HIV/AIDS, autoimmune diseases, drug testing, nephrology, and other applications. The infectious diseases segment accounted for the largest share of ~25% of the In Vitro Diagnostics market in 2014.

In this report, this global market is studied at regional and country levels. In 2014, North America commanded the largest share of the market, and this region is poised to dominate the market during the forecast period. However, the Asia-Pacific region is expected to be the fastest-growing regional market in the coming years. The growth in this region is attributed to the increasing investment by leading players, and respective government agencies, and increasing demand for diagnostic tests from large patient population in the region.

The major players in the global In Vitro Diagnostics market are Roche Diagnostics Limited (Switzerland), Abbott Laboratories, Inc. (U.S.), Becton, Dickson and Company (U.S.), Johnson and Johnson (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories, Inc. (U.S.), Sysmex Corporation (Japan), and bioMιrieux (France).

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports